Kayla Teives
Family · Clarksville, INNPI 1124565239
Payments from drug & device makers
Across 570 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AstraZeneca$800
- Vanda Pharmaceuticals Inc.$558
- Neurocrine Biosciences, Inc.$542
- Alkermes, Inc.$507
- plus $4K from 22 others
What the payments were for
- Food & beverage$9,515100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 166 | $1,903 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 98 | $1,511 |
| AstraZeneca | 11 | $800 |
| Vanda Pharmaceuticals Inc. | 27 | $558 |
| Neurocrine Biosciences, Inc. | 38 | $542 |
| Alkermes, Inc. | 27 | $507 |
| Lundbeck LLC | 35 | $482 |
| Otsuka America Pharmaceutical, Inc. | 30 | $475 |
| Teva Pharmaceuticals USA, Inc. | 17 | $333 |
| Gilead | 11 | $272 |
| Biohaven Pharmaceuticals, Inc. | 11 | $256 |
| GSK | 8 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $254 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $220 |
| Johnson & Johnson | 12 | $214 |
| Sunovion Pharmaceuticals Inc. | 11 | $193 |
| Idorsia Pharmaceuticals US Inc | 6 | $193 |
| Novo Nordisk | 8 | $145 |
| Indivior Inc. | 7 | $111 |
| Exact Sciences | 4 | $87 |
| Eisai Inc. | 6 | $79 |
| Merck | 1 | $22 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Bayer | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$333
- NURTEC ODT$238
- FARXIGA$134
- BREZTRI$125
- AIRSUPRA$125
- Descovy$120
- QUVIVIQ$120
- TRELEGY ELLIPTA$118
- CAPLYTA$115
How this compares
$9,515 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $51,075 |
| FarxigaDapagliflozin Propanediol | 42 | $35,136 |
| OzempicSemaglutide | 27 | $26,638 |
| JardianceEmpagliflozin | 11 | $8,114 |
| VascepaIcosapent Ethyl | 15 | $5,074 |
| Fenofibrate | 20 | $2,223 |
| Atorvastatin Calcium | 190 | $1,687 |
| Levothyroxine Sodium | 90 | $1,081 |
| Pantoprazole Sodium | 80 | $901 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $762 |
| Metoprolol Succinate | 43 | $744 |
| Ventolin HfaAlbuterol Sulfate | 14 | $723 |
| Midodrine Hcl | 14 | $614 |
| Lisinopril | 103 | $605 |
| Amlodipine Besylate | 105 | $605 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $255 | $51,07557 claims |
| AstraZenecaFarxiga | $800 | $35,13642 claims |
| Novo NordiskOzempic | $145 | $26,63827 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,392 family providers in Indiana.
Other family in Clarksville
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.